Outback road pindan dirt
Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

ASX-listed explorer Adavale Resources (ASX:ADD) is gearing up to commence exploration drilling for uranium in south Australia as the nuclear fuel feedstock prices stay attractively high (despite intrayear losses).

Drilling and survey contracts are being finalised for the company’s Marree Embayment which envelopes 100% interests acquired by Adavale in a licence area from Kilonova Metals.

Relatively low-cost aircore drilling is being used in the first 3,000m drill run seeking extensions at two key prospect targets of interest. While historical drilling data is available, historical assays are based on very short drill core intercept widths.

Company Executive Director David Riekie was the first to note this shortcoming (in typical ASX corpspeak.)

“While the historical drilling outlined the general uranium prospectivity, our current program of up to 40 holes is anticipated to trace, extend and test the uranium redox boundaries that were previously intersected,” Riekie said.

“This current drilling program will include both infill drilling (200m x 100m), designed to confirm and extend the previous uranium mineralisation as well as some broader spaced (800m x 400m) drilling anticipated to generate new target areas.”

The company’s pivot to uranium is understandable – it’s other main project is a nickel play in Tanzania.

ADD last traded at 0.4cps.

ADD by the numbers
More From The Market Online
Market concept

(Last) Market Close (of 2025): October back again as DRO, EOS & 4DX pop; otherwise mid day

If you wanted to feel like you were re-living the festivity season for the XJO that was October, look no further than today’s

EV Resources on ‘accelerated pathway’ to Los Lirios restart after strong antimony recovery tests

EV Resources is inching closer to a Los Lirios restart after strong metallurgical results set up…
Magneto scan concept

MRI scans changed medicine – what disruptive tech is next? Enter Compumedics, up +50% YoY

Compumedics, a biotech company developing its Orion Lifespan MEG product, could just be the next big…

Coles, Woolies left furious over gov’t checks designed to limit ‘excessive pricing on groceries’

Coles and Woolworths have come out swinging against the government's plan to impose stricter rules to…